Ireland Cancer Trial Access Warning

A report by Advocacy Lab has warned Ireland is significantly underrepresented in EU cancer trials, with only 1.1% of trials occurring within the country. This disparity raises serious concerns about patient access to cutting-edge research and treatment options. The issue highlights potential inequities in clinical trial distribution across the European Union.

Summarized from the sources above. Read the originals for the full story.